Suppr超能文献

相似文献

1
Activated protein C in severe acute pancreatitis without sepsis? Not just yet ..
Crit Care. 2010;14(4):188. doi: 10.1186/cc9190. Epub 2010 Aug 9.
2
APCAP--activated protein C in acute pancreatitis: a double-blind randomized human pilot trial.
Crit Care. 2010;14(4):R139. doi: 10.1186/cc9203. Epub 2010 Jul 27.
3
Recombinant human activated protein C as a disease modifier in severe acute pancreatitis: systematic review of current evidence.
Pancreatology. 2012 Mar-Apr;12(2):119-23. doi: 10.1016/j.pan.2012.01.002. Epub 2012 Jan 6.
4
Drotrecogin alfa (recombinant human activated protein C) in severe acute pancreatitis.
Crit Care. 2005 Aug;9(4):321-2. doi: 10.1186/cc3777. Epub 2005 Jul 20.
5
Continuing challenges of sepsis research.
JAMA. 2001 Oct 17;286(15):1894-6. doi: 10.1001/jama.286.15.1894.
7
New thoughts on sepsis: the unifier of critical care.
Dimens Crit Care Nurs. 2003 Jan-Feb;22(1):20-30. doi: 10.1097/00003465-200301000-00004.
8
Activated protein C retards recovery from coagulopathy in severe acute pancreatitis.
Scand J Clin Lab Invest. 2016;76(1):10-6. doi: 10.3109/00365513.2015.1084041. Epub 2015 Sep 24.
9
Intestinal barrier damage, systemic inflammatory response syndrome, and acute lung injury: A troublesome trio for acute pancreatitis.
Biomed Pharmacother. 2020 Dec;132:110770. doi: 10.1016/j.biopha.2020.110770. Epub 2020 Oct 2.

引用本文的文献

1
Burn-Related Glycocalyx Derangement and the Emerging Role of MMP8 in Syndecan Shedding.
Biology (Basel). 2025 Mar 6;14(3):269. doi: 10.3390/biology14030269.
2
Activated Protein C in Cutaneous Wound Healing: From Bench to Bedside.
Int J Mol Sci. 2019 Feb 19;20(4):903. doi: 10.3390/ijms20040903.
4
Pathogenic mechanisms of acute pancreatitis.
Curr Opin Gastroenterol. 2012 Sep;28(5):507-15. doi: 10.1097/MOG.0b013e3283567f52.
5
Molecular mechanisms of pancreatic injury.
Curr Opin Gastroenterol. 2011 Sep;27(5):444-51. doi: 10.1097/MOG.0b013e328349e346.

本文引用的文献

1
APCAP--activated protein C in acute pancreatitis: a double-blind randomized human pilot trial.
Crit Care. 2010;14(4):R139. doi: 10.1186/cc9203. Epub 2010 Jul 27.
4
Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock.
Intensive Care Med. 2008 Nov;34(11):1935-47. doi: 10.1007/s00134-008-1266-6. Epub 2008 Oct 7.
6
Practical aspects of treatment with drotrecogin alfa (activated).
Crit Care. 2007;11 Suppl 5(Suppl 5):S7. doi: 10.1186/cc6158.
7
Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated).
Am J Respir Crit Care Med. 2007 Sep 1;176(5):483-90. doi: 10.1164/rccm.200612-1803OC. Epub 2007 Jun 7.
9
Management of the critically ill patient with severe acute pancreatitis.
Crit Care Med. 2004 Dec;32(12):2524-36. doi: 10.1097/01.ccm.0000148222.09869.92.
10
Disorders of hemostasis during the surgical management of severe necrotizing pancreatitis.
Pancreas. 2004 Aug;29(2):152-6. doi: 10.1097/00006676-200408000-00010.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验